How Has the Lisinopril Market Evolved Historically and What is its Current Size?
The lisinopril market has seen considerable growth due to a variety of factors.
• The lisinopril market has experienced solid growth recently. It will grow from $1.76 billion in 2024 to $1.88 billion in 2025, with a CAGR of 6.7%.
Growth is driven by improved accessibility, shifts in lifestyle, more widespread screening programs, easier access to generic lisinopril, and higher patient adherence.
What Is The Projected Growth Of The Lisinopril Template Market?
The lisinopril market is expected to maintain its strong growth trajectory in upcoming years.
• The lisinopril market is expected to see steady growth, reaching $2.4 billion by 2029, with a CAGR of 6.3%.
Growth will be driven by the rising prevalence of hypertension and cardiovascular diseases, the availability of cost-effective generic versions, increased awareness and early diagnosis, and growing demand for effective treatments for heart failure and diabetic kidney disease. Trends include innovations in drug delivery, patient-centric solutions, and the demand for more effective and affordable treatments.
What Are The Key Drivers Fueling Growth In The Lisinopril Market?
The rising prevalence of cardiovascular diseases is expected to boost the lisinopril market. Cardiovascular diseases, including heart and blood vessel disorders, are increasing due to population aging and poor lifestyle choices. Lisinopril helps manage these diseases by lowering blood pressure and reducing strain on the heart and kidneys. According to the Singapore Heart Foundation, ischemic heart diseases caused 5,302 deaths in 2023. As a result, the rising prevalence of cardiovascular diseases is driving the lisinopril market.
What Are The Principal Market Segments In The Global Lisinopril Industry?
The lisinopril market covered in this report is segmented –
1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases
3) By Dosage: Tablet, Liquid, Other Dosages
4) By Population Type: Children, Adults
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Zestoretic: Different Dosage Forms, Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms, Generic Versions Of Zestril
4) By Other Brands: International Brand Variants, Combination Drug Formulations
Pre-Book The Lisinopril Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Lisinopril Market?
Major companies operating in the lisinopril market are:
• Merck & Co. Inc.
• Pfizer Inc.
• AbbVie Inc.
• AstraZeneca Plc
• Vitaris Inc.
• Teva Pharmaceutical Industries Limited
• Bausch Health Companies Inc.
• Hetero Ltd.
• Sun Pharmaceutical Industries Limited
• Aurobindo Pharma Ltd.
• Cipla Inc.
• Hikma Pharmaceutical Plc
• Apotex Inc.
• Amneal Pharmaceutical Inc.
• Lupin Ltd.
• Zhejiang Huahai Pharmaceutical Co. Ltd.
• Metrochem API Private Limited
• Calyx Chemicals & Pharmaceuticals Limited
• Farmhispania Group
• Zydus Cadila Healthcare Ltd.
• Qingdao Qingmei Biotech Co. Ltd.
• LGM Pharma LLC
• Amara Labs Pvt.
• Sms Lifesciences
What Are The Regional Insights Into The Lisinopril Market?
North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
